Cargando…
Bevacizumab treatment of meningeal melanoma metastases
BACKGROUND: Melanoma patients with metastatic growth in the meninges have poor prognosis and few treatment options. Although treatment with BRAF inhibitors or immune checkpoint inhibitors has provided promising results, most patients with advanced melanoma are resistant to these treatments and devel...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947957/ https://www.ncbi.nlm.nih.gov/pubmed/31915016 http://dx.doi.org/10.1186/s12967-020-02212-3 |